Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance
- PMID: 40808905
- PMCID: PMC12345048
- DOI: 10.1017/ash.2025.10072
Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance
Conflict of interest statement
EW has received honoraria from Roche Diagnostics and Elsevier. PAR has received funding from Pfizer for a respiratory surveillance program independent of EIP and the reported work.
Similar articles
-
Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China.Emerg Microbes Infect. 2024 Dec;13(1):2332658. doi: 10.1080/22221751.2024.2332658. Epub 2024 Apr 3. Emerg Microbes Infect. 2024. PMID: 38517707 Free PMC article.
-
Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations.Antimicrob Agents Chemother. 2025 Jul 25:e0053325. doi: 10.1128/aac.00533-25. Online ahead of print. Antimicrob Agents Chemother. 2025. PMID: 40711423
-
In Vitro Activity of New β-Lactam-β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Surveillance Network (CHINET) in 2019.Microbiol Spectr. 2022 Aug 31;10(4):e0185422. doi: 10.1128/spectrum.01854-22. Epub 2022 Jul 12. Microbiol Spectr. 2022. PMID: 35862963 Free PMC article.
-
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections.Infect Dis Ther. 2020 Dec;9(4):757-767. doi: 10.1007/s40121-020-00350-1. Epub 2020 Oct 5. Infect Dis Ther. 2020. PMID: 33017041 Free PMC article. Review.
-
New β-Lactam-β-Lactamase Inhibitor Combinations.Clin Microbiol Rev. 2020 Nov 11;34(1):e00115-20. doi: 10.1128/CMR.00115-20. Print 2020 Dec 16. Clin Microbiol Rev. 2020. PMID: 33177185 Free PMC article. Review.
References
-
- Biomerieux. BIOFIRE® Blood Culture Identification 2 (BCID2) Panel, 2024. https://www.biomerieux.com/us/en/our-offer/clinical-products/biofire-blo...Accessed November13, 2024
-
- Roche Diagnostics. cobas® eplex Blood Culture Identification Panels, 2024. https://diagnostics.roche.com/us/en/products/params/eplex-bcid-panels.html. Accessed November 13, 2024
-
- Diasorin. VERIGENE® Gram-Negative Blood Culture Test, 2024.https://us.diasorin.com/en/molecular-diagnostics/kits-reagents/verigene-.... Accessed November 13, 2024.
-
- Karlsson M, Lutgring JD, Ansari U, et al. Molecular characterization of carbapenem-resistant enterobacterales collected in the United States. Microb Drug Resist 2022;28:389–397. - PubMed
LinkOut - more resources
Full Text Sources